Nonpharmaceutical Interventions for Pandemic Influenza, International Measures

Unknown author(s)

Emerging infectious diseases · 2006 · 336 citations · 32 references

DOIFull text

Open access

Concepts

TL;DR

WHO recommends non‑pharmaceutical interventions because vaccines and antivirals are insufficient and influenza transmission is rapid, often peaking early, with short intervals between cases and occasional asymptomatic spread. The study recommends informing international travelers and possibly screening those leaving affected countries, emphasizing that pandemic control should focus on national and community measures rather than border restrictions. Border screening and quarantine of travelers have proven ineffective at delaying virus introduction in most past pandemics and are expected to be even less effective today.

Abstract

Since global availability of vaccine and antiviral agents against influenza caused by novel human subtypes is insufficient, the World Health Organization (WHO) recommends non-pharmaceutical public health interventions to contain infection, delay spread, and reduce the impact of pandemic disease. Virus transmission characteristics will not be completely known in advance, but difficulties in influenza control typically include peak infectivity early in illness, a short interval between cases, and to a lesser extent, transmission from persons with incubating or asymptomatic infection. Screening and quarantining entering travelers at international borders did not substantially delay virus introduction in past pandemics, except in some island countries, and will likely be even less effective in the modern era. Instead, WHO recommends providing information to international travelers and possibly screening travelers departing countries with transmissible human infection. The principal focus of interventions against pandemic influenza spread should be at national and community levels rather than international borders.

References

32